Recombinant Human Interferon-Gamma: Prospects for the Treatment of Chronic Epstein-Barr Viral Infection
Infection of Epstein-Barr virus (EBV) is about 90% among people over the age of 40. The EBV causes a chronic infection that is characterized by chronic or recurrent symptoms and persists for a long time. Recombinant interferon-gamma (IFN-γ) has high clinical and antiviral efficacy in the treatment o...
Saved in:
Main Authors: | Rakityanskaya, Irina A. (Author), Ryabova, Tatiana S. (Author) |
---|---|
Format: | Ebooks |
Published: |
IntechOpen,
2021-12-02.
|
Subjects: | |
Online Access: | Get Online |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epstein-Barr Virus : New Trends
Published: (2021) -
Epstein-Barr Virus-Associated Gastric Carcinoma: The Americas' Perspective
by: Alarcón, Alejandra, et al.
Published: (2017) -
Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases
Published: (2019) -
Epstein-Barr Virus: Should We Still Invest in Vaccines or Focus on Predictive Tests?
by: Drouet, Emmanuel
Published: (2021) -
Drug Re-Purposing for the Treatment of Bacterial and Viral Infections
Published: (2019)